Newsfeeds - Spark Newswire

2 minute read

News

The Omicron Variant Of SARS-CoV-2 Has Minimal Impact On The T Cell Epitopes Contained Within Gritstone’s Self-Amplifying mRNA COVID-19 Vaccines

Today, 5:33 AM

Gritstone bio, Inc. (NASDAQ:GRTS), a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, today announced that the SARS-CoV-2 T cell epitopes (TCEs) administered

GRTS

1 minute read

Gritstone Announces Preclinical Data In Non-Human Primate Challenge Study With Second-Generation COVID-19 Vaccine Against SARS-CoV-2

By Benzinga Newsdesk

Today, 5:33 AM

Self-amplifying mRNA (SAM) vaccination protected against SARS-CoV-2 challenge as both a 2-dose regimen and as a single boost following ChAd prime in rhesus macaques Potential for equivalent or more potent immune

GRTS

1 minute read

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

Today, 5:33 AM

ARTL

1 minute read

Gritstone Oncology Q3 EPS $(0.36) Up From $(0.69) YoY, Sales $2.61M Up From $939.00K YoY

By Benzinga Newsdesk

Today, 5:33 AM

Gritstone Oncology (NASDAQ:GRTS) reported quarterly losses of $(0.36) per share. This is a 47.83 percent increase over losses of $(0.69) per share from the same period last year. The company reported $2.61 million in

GRTS

3 minute read

Gritstone Announces Dosing Of First Volunteer In Trial Evaluating Self-Amplifying mRNA As A COVID-19 Vaccine Booster And Immunogenicity Enhancer

By Benzinga Newsdesk

Today, 5:33 AM

GRTS

4 minute read

48 Biggest Movers From Friday

By Lisa Levin

Today, 5:33 AM

Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by AstraZeneca for patients with unresectable, stage 3 non-small cell lung cancer.

AKYA

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

Today, 5:33 AM

Gainers

CRVS

5 minute read

The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera’s COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold

By Shanthi Rexaline

Today, 5:33 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16)

ABCL

4 minute read

Gristone Reports Clinical Data With GRANITE During European Society Of Medical Oncology, Launch Of Randomized Clinical Trial Program For Colorectal Cancer With Registrational Intent

By Benzinga Newsdesk

Today, 5:33 AM

GRANITE individualized immunotherapy demonstrates objective evidence of efficacy in end-stage colorectal cancer (CRC) patients (3rd line or greater) who have “cold” tumors at baseline 44% molecular

BMY

1 minute read

5 Stocks To Watch For September 17, 2021

By Lisa Levin

Today, 5:33 AM

Some of the stocks that may grab investor focus today are: Wall Street expects Manchester United plc (NYSE: MANU) to report a quarterly loss at $0.15 per share on revenue of $104.00 million before the opening bell. Manchester United shares gained 0.6% to close at $17.62 on Thursday.

CARR